Skip to main content
MJH Life Sciences
  • Login
  • Register
  • Login
  • Register
Home
  • Topics
  • Acne
  • Atopic Dermatitis
  • Psoriasis
  • Rosacea
  • Skin Cancer
  • Anti-Aging
  • NPPA Community
  • Derm Pulse
MJH Life Sciences

SUBSCRIBE: Print / Digital / eNewsletter

Manuka honey tested as AD treatment

October 6, 2017
  • Modern Medicine Feature Articles, Modern Medicine Feature Articles, Modern Medicine News, Dermatology, Atopic Dermatitis, Eczema Treatments

An open-label, pilot study has found that the topical application of manuka honey may be effective in treating atopic dermatitis lesions.

Abdullah A. Alangari M.D., the study’s lead author and an allergist at King Saud University in Saudi Arabia, says he was prompted to investigate the impact of honey after receiving anecdotal reports from patients saying they benefited from using honey to treat atopic dermatitis lesions. The study appears in a recent issue of Immunity, Inflammation and Disease.

Honey is well-recognized for its medicinal qualities and is currently being employed in wound care and as a burn treatment. Other studies have shown that it can provide antibiotic resistance to specific strains of bacteria. It's health properties are continually under study throughout the world. 

In this study, investigators recruited 16 individuals (8 female, mean age 33), but two withdrew due to worsening symptoms. “We asked patients with bilateral atopic dermatitis lesions to place honey topically on one site overnight and leave the contralateral site untreated. We noted that on average the lesions treated with honey improved more than lesions that were untreated,” he said.

A three-item severity score was significantly lower after one week of treatment as compared to baseline with a mean difference of  -2 points (P< 0.001). There were no significant differences in the score between control lesions pre-treatment and post-treatment (p=0.15). Topical honey was well-tolerated. None of 14 participants after one week of topical manuka honey use reported any adverse events.

Staphylococcus aureus colonizes the skin of the vast majority of patients with atopic dermatitis. Investigators cultured Staph aureus pre-treatment and after seven days of treatment, but found no difference in skin staphylococci regardless of treatment.

Investigators also examined the secretion of CCL26 (eotaxin 3) by keratinocytes, which is upregulated by IL-4 and has a critical role in the pathogenesis of atopic dermatitis and other conditions, such as asthma, where eosinophils contribute to a large degree. They found that honey could significantly downregulate IL4-induced CCL26 secretion in a dose-dependent way (P< 0.001). They also found that treatment with manuka honey significantly inhibited mast cell degranulation by evaluating histamine release.

“More studies need to be done to further understand the mechanism of action of honey in atopic dermatitis,” Dr. Alangari said.

 

 


References

Alangari AA, Morris K, Lwaleed BA, et al. Honey is potentially effective in the treatment of atopic dermatitis: Clinical and mechanistic studies. Immunity, Inflammation and Disease. 2017; 5(2): 190-99.

 

Related Articles

  • Stop and re-start biologics are tricky in psoriasis
  • An alternative way to adopt corticosteroids safely
  • Botulinum toxin injections may improve scarring
  • Vertical dermatology integration without dermatologists
  • Systemic conditions that affect skin

Resource Topics rightRail

  • Resource Topics
  • Partner Content
  • Melasma and Hyperpigmentation Treatments
  • Treatments for Plaque Psoriasis
  • Derm Pulse
  • Current and Emerging Treatments for Acne
  • Videos Atopic Dermatitis
Treatment of Plaque Psoriasis
The management of Atopic Dermatitis Across the Generations
CME Activities
Advancements in Aesthetics Technology Podcast Series
Discovering the Versatility of the CO2RE Platform to Treat Dermatologic, Aesthetic, and Gynecologic Applications
Derm NP and PA discussion forum

Current Issue

Dermatology Times, December 2019 (Vol. 40, No. 12)
Dec 03, 2019 Vol 40 No 12
Digital Edition
Connect with Us
  • Column 1
    • Home
    • About Us
    • Contact Us
  • Column 2
    • Editorial Info
  • Column 3
    • Advertising Info
    • Reprints
    • Advertising Terms
  • Column 4
    • Terms of Use
    • Privacy Policy
Modern Medicine Network
© UBM 2019, All rights reserved.
Reproduction in whole or in part is prohibited.

We've noticed that you're using an ad blocker

Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker.

It's off now Dismiss How do I disable my ad blocker?
❌

How to disable your ad blocker for our site:

Adblock / Adblock Plus
  • Click on the AdBlock / AdBlock Plus icon on the top right of your browser.
  • Click “Don’t run on pages on this domain.” OR “Enabled on this site.”
  • Close this help box and click "It's off now".
Firefox Tracking Prevention
  • If you are Private Browsing in Firefox, "Tracking Protection" may casue the adblock notice to show. It can be temporarily disabled by clicking the "shield" icon in the address bar.
  • Close this help box and click "It's off now".
Ghostery
  • Click the Ghostery icon on your browser.
  • In Ghostery versions < 6.0 click “Whitelist site.” in version 6.0 click “Trust site.”
  • Close this help box and click "It's off now".
uBlock / uBlock Origin
  • Click the uBlock / uBlock Origin icon on your browser.
  • Click the “power” button in the menu that appears to whitelist the current website
  • Close this help box and click "It's off now".